Apple Cider Vinegar

Presentation Slides

Chinese Medicine Research Hub

Systematic Review

Consumption of apple cider vinegar significantly improves certain risk factors for cardiometabolic syndrome, notably fasting blood glucose, glycosylated hemoglobin, and total cholesterol.

2023 Current Medicinal Chemistry The Effects of Apple Cider Vinegar on Cardiometabolic Risk Factors: A Systematic Review and Meta-analysis of Clinical Trials
Dadkhah Tehrani S, Keshani M, Rouhani MH, Moallem SA, Bagherniya M, Sahebkar A

Chinese Medicine Research Hub

Systematic Review

Apple cider vinegar intake can significantly decrease total cholesterol and fasting plasma glucose levels contributing to better cardiovascular health among adults.

2021 BMC Complementary Medicine and Therapies The effect of apple cider vinegar on lipid profiles and glycemic parameters: a systematic review and meta-analysis of randomized clinical trials
Hadi A, Pourmasoumi M, Najafgholizadeh A, Clark CCT, Esmaillzadeh A

Executive Summary

Write an executive summary in the form of a blog article on the topic of "Research into Chinese medicine treatment for Apple Cider Vinegar" summarising the research below and using language that can be easily understood by patients and avoiding medical jargon using a professional and caring tone of voice.

Write an executive summary in the form of a blog article on the topic of "Researched Chinese medicine treatments for Apple Cider Vinegar" summarising the research below in an objective and easy to understand way, and using language that can be easily understood by patients. Group the article into Chinese medicine treatments first, followed by nutrition and other treatments. Avoid using medical jargon and use a professional and caring tone of voice.

Write me a concise but easy to understand executive summary on the topic of "Chinese medicine treatments for Apple Cider Vinegar" based on the following research that I will give you. Your summary should be 2 paragraphs long in Australian English spelling and include references to the studies.

A Systematic Review published in 2023 in the journal Current Medicinal Chemistry found that Consumption of apple cider vinegar significantly improves certain risk factors for cardiometabolic syndrome, notably fasting blood glucose, glycosylated hemoglobin, and total cholesterol. This study applied a systematic review and meta-analysis of clinical trials found in PubMed, Scopus, and ISI Web of Science databases. In this process, trials evaluating the effects of apple cider vinegar consumption on cardiometabolic syndrome risk factors were sought. In total, 25 clinical trials were included in the study, these trials encompassed 1320 adult participants. The consumed apple cider vinegar led to a general improvement in fasting blood glucose, glycosylated hemoglobin, and total cholesterol. However, for body mass index, insulin resistance, serum insulin, triglycerides, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol, no significant results were observed. Conducting a subgroup analysis, the study identified a significant decrease in fasting blood glucose, glycosylated hemoglobin, total cholesterol, and triglycerides in diabetic patients. Further, it was observed that the apple cider vinegar significantly reduced fasting blood glucose levels regardless of the duration of administration and also decreased triglycerides concentration when consumed for 12 weeks or more.

A Systematic Review published in 2021 in the journal BMC Complementary Medicine and Therapies found that Apple cider vinegar intake can significantly decrease total cholesterol and fasting plasma glucose levels contributing to better cardiovascular health among adults. The research process involved a thorough examination of electronic databases such as Medline, Scopus, Cochrane Library, and Web of Knowledge, from their creation until January 2020. The goal was to discover any clinical trial that explored the influence of apple cider vinegar (ACV) on lipid profiles and glycemic indicators. Studies where ACV was combined with other interventions or where the intervention duration was less than two weeks were excluded. To manage the differences between studies, a random-effects model was applied during the meta-analysis process comprising nine studies, including ten study arms. ACV use demonstrated a remarkable decrease in total cholesterol and fasting plasma glucose (FPG) levels. However, there wasn't a noticeable impact observed on LDL-C, HDL-C, fasting insulin concentrations, or HOMA-IR serum levels. When analyzed further, it was found that a reduction in serum TC and TG occurred in a patient subgroup with type 2 diabetes, those who consumed less than or equal 15 mL/day of ACV, and those who consumed it for over 8-weeks. Consequently, a significant decrease in FPG levels was found in studies where participants consumed ACV for more than 8 weeks. Interestingly, FPG and HDL-C levels appeared to increase in participants who were otherwise healthy.

Moderation Tools

Topic